Posted on May 9th, 2016 by
The regular use of aspirin significantly reduces the overall risk of cancer, especially colorectal and other gastrointestinal tract cancers, according to a study published in JAMA Oncology.1
The recent report supports the results of previous clinical studies that have also demonstrated that the daily use of aspirin reduces the risk of death from several common cancers, including lung, colorectal, and esophageal cancers.2
Take home points from the current JAMA study:
The authors concluded that their findings imply that aspirin use would be expected to prevent a significant number of colorectal cancers above and beyond those that would be prevented by screening and may have even greater benefit in settings in which the resources to devote to cancer screening are lacking. Individuals should consider taking aspirin to reduce their risk of colorectal cancer, particularly those with other reasons for regular use, such as heart disease prevention. However, due to certain risks associated with aspirin (such as bleeding in the brain), individuals should discuss daily aspirin use with their doctor before beginning a preventive regimen.
Copyright © 2017 CancerConnect. All Rights Reserved.
You must be logged-in to the site to post a comment.